United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses ... 2025--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today ...

Sangamo Therapeutics, Inc.’s SGMO share price has surged by 10.12%, which has investors questioning if this is right time to ...

Danaher Corporation’s DHR share price has surged by 6.12%, which has investors questioning if this is right time to sell.

United Therapeutics Corp. operates as a biotechnology company ... and infectious diseases and cancer. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in ...

Proposed transaction will raise $50 million in equity capital and enhance a publicly traded biopharmaceutical company focused on launching ...

Dogs of the Dow stocks are not only higher on the year but still offer big yields and a degree of safety from tariffs.

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (UTHR) announced today that it will report its first quarter 2025 financial results before the ...

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...